Vaccine breakthrough infectionsYeast recombinant hepatitis B vaccineBackground:The long-term protective effect of hepatitis B vaccine (HepB), the incidence of hepatitis B virus (HBV) vaccine breakthrough infections (VBIs), and whether a booster HepB is necessary remain to be clarified in children...
Healthcare workers may need booster hepatitis B vaccinationHepatitis-B, preventionHepatitis-B-vaccine, therapeutic useHepatitis-B-vaccine, immunogenicityInpharma Weekly -doi:10.2165/00128413-200012350-00008NoneSpringer International PublishingInpharma Weekly...
Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine. Although the efficacy of vaccine is well documented, the duration of immunity of healthy adults after vaccination is unknown. We studied 245 hospital employees 3 years after primary vaccination with B vaccine to...
Current consensus does not support the use of a universal booster of hepatitis B virus (HBV) vaccine because there is an anamnestic response in almost all children 15 years after universal infant HBV vaccination. We aimed to provide a booster strategy among adolescents as a result of their chang...
Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose We here studied the antibody response to a booster dose four years after the administration of one single dose of recombinant HB vaccine. Before receiving ... Johan Wistrm a,Clas Ahlm a,Sonia ...
Response of Booster Dose of Cuban Recombinant Hepatitis-B Vaccine in Nonresponder and Hyporesponder Children. Pak J Med Sci 2007;23(1):23-6.Dahifar F, Mousavi F, Ghorbani A. Response of booster dose of Cuban recombinant hepatitis B vaccine in non-responder and hyporesponder children. Pak ...
1.Study of Immune Efficacy on Booster of Hepatitis B Vaccine among Children;儿童乙型肝炎疫苗加强免疫效果研究 英文短句/例句 1.Proteomic Analysis to Augmented Immune Responses in Mouse by Prime-and-Boost Immunization Strategy with HBsAg DNA and Protein Vaccine;乙肝表面抗原DNA疫苗初免—蛋白疫苗加强免疫...
Nineteen healthy young adults were vaccinated with plasma-derived hepatitis B vaccine at months 0, 1, and 12, and their immune responses were compared to those of a similar group of 20 vaccinees immunized at months 0, 1, and 6. Late booster injections at 12 months produced nearly fivefold ...
Timing of hepatitis B revaccination in healthy adults Lancet (1987) Sc Hadler et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men N Engl J Med (1986) W. Jilg et al. Persistence of antibodies against hepatitis B surface antigen after vaccination against hepatiti...
Our objective was to evaluate the long-term antibody persistence of such a combined vaccine in an area of high hepatitis B endemicity. We have shown that a DTPw-HB vaccine was safe and immunogenic when given as a booster dose at 18 months of age. One month after the booster dose of ...